183 related articles for article (PubMed ID: 31177018)
1. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
Du LJ; Feng YX; He ZX; Huang L; Wang Q; Wen CP; Zhang Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1521-1533. PubMed ID: 34552214
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
5. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells.
Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J
Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL
Soto M; Delatorre N; Hurst C; Rodgers KE
Front Immunol; 2020; 11():1572. PubMed ID: 32793221
[TBL] [Abstract][Full Text] [Related]
7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.
Wang J; Mizui M; Zeng LF; Bronson R; Finnell M; Terhorst C; Kyttaris VC; Tsokos GC; Zhang ZY; Kontaridis MI
J Clin Invest; 2016 Jun; 126(6):2077-92. PubMed ID: 27183387
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
Edwards LJ; Mizui M; Kyttaris V
Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
[TBL] [Abstract][Full Text] [Related]
10. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
11. Calcium signaling in systemic lupus erythematosus T cells: a treatment target.
Kyttaris VC; Zhang Z; Kampagianni O; Tsokos GC
Arthritis Rheum; 2011 Jul; 63(7):2058-66. PubMed ID: 21437870
[TBL] [Abstract][Full Text] [Related]
12. Tofacitinib Ameliorates Lupus Through Suppression of T Cell Activation Mediated by TGF-Beta Type I Receptor.
Yan Q; Chen W; Song H; Long X; Zhang Z; Tang X; Chen H; Lin H; Sun L
Front Immunol; 2021; 12():675542. PubMed ID: 34394075
[TBL] [Abstract][Full Text] [Related]
13. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
14. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
15. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
16. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
Qiu F; Li T; Zhang K; Wan J; Qi X
Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
[TBL] [Abstract][Full Text] [Related]
19. ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings.
Weiss JM; Chen W; Nyuydzefe MS; Trzeciak A; Flynn R; Tonra JR; Marusic S; Blazar BR; Waksal SD; Zanin-Zhorov A
Sci Signal; 2016 Jul; 9(437):ra73. PubMed ID: 27436361
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
